BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ackerman M, Henry D, Finon A, Binois R, Esteve E. Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021;35:e423-5. [PMID: 33783017 DOI: 10.1111/jdv.17248] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Tozinameran. Reactions Weekly 2022;1937:438-438. [DOI: 10.1007/s40278-022-30118-2] [Reference Citation Analysis]
2 Yan M, Zhao H, Li Z, Chow J, Zhang Q, Qi Y, Wu S, Zhong M, Qiu X. Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.921760] [Reference Citation Analysis]
3 Taha Gul Shaikh, Summaiyya Waseem, Syed Hassan Ahmed, Nashwa Abdul Qadir, Vincenzo Piccolo. SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far? Dermatol Pract Concept 2022;12:e2022170. [PMID: 36534559 DOI: 10.5826/dpc.1204a170] [Reference Citation Analysis]
4 Tan LJ, Koh CP, Lai SK, Poh WC, Othman MS, Hussin H. A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination. Forensic Sci Int 2022;340:111469. [PMID: 36162300 DOI: 10.1016/j.forsciint.2022.111469] [Reference Citation Analysis]
5 Corey KB, Koo G, Phillips EJ. Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:2254-2266. [DOI: 10.1016/j.jaip.2022.04.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Magdalena Dumitru I. Side Effects of the COVID-19 Vaccines. COVID-19 Vaccines - Current State and Perspectives [Working Title] 2022. [DOI: 10.5772/intechopen.105668] [Reference Citation Analysis]
7 Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther 2022;7:146. [PMID: 35504917 DOI: 10.1038/s41392-022-00996-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
8 Kobayashi A. Generalized Erythematous Rash After Administration of Pfizer COVID-19 mRNA Vaccine. Nishinihon J Dermatol 2022;84:85-86. [DOI: 10.2336/nishinihonhifu.84.85] [Reference Citation Analysis]
9 Kroumpouzos G, Paroikaki ME, Yumeen S, Bhargava S, Mylonakis E. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review. Microorganisms 2022;10:624. [DOI: 10.3390/microorganisms10030624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Cau R, Mantini C, Monti L, Mannelli L, Di Dedda E, Mahammedi A, Nicola R, Roubil J, Suri JS, Cerrone G, Fanni D, Faa G, Carriero A, Scuteri A, Francone M, Saba L. Role of imaging in rare COVID-19 vaccine multiorgan complications. Insights Imaging 2022;13. [DOI: 10.1186/s13244-022-01176-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, Conforti C. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol 2022. [PMID: 35141881 DOI: 10.1111/ijd.16063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
12 Fasano G, Bennardo L, Ruffolo S, Passante M, Ambrosio AG, Napolitano M, Provenzano E, Nisticò SP, Patruno C. Erythema Migrans-like COVID Vaccine Arm: A Literature Review. J Clin Med 2022;11:797. [PMID: 35160249 DOI: 10.3390/jcm11030797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Gronbeck C, Grant-Kels JM. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them! Clin Dermatol 2021;39:674-87. [PMID: 34809772 DOI: 10.1016/j.clindermatol.2021.05.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
14 Temiz SA, Abdelmaksoud A, Wollina U, Kutlu O, Dursun R, Patil A, Lotti T, Goldust M, Vestita M. Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review. J Cosmet Dermatol 2021. [PMID: 34791757 DOI: 10.1111/jocd.14613] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
15 Desai HD, Sharma K, Shah A, Patoliya J, Patil A, Hooshanginezhad Z, Grabbe S, Goldust M. Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review. J Cosmet Dermatol 2021;20:3350-61. [PMID: 34719084 DOI: 10.1111/jocd.14521] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
16 Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, Barras M, Stücker M, Kasakovski D. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2021. [PMID: 34661927 DOI: 10.1111/jdv.17744] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 26.5] [Reference Citation Analysis]
17 Alhumaid S, Al Mutair A, Al Alawi Z, Rabaan AA, Tirupathi R, Alomari MA, Alshakhes AS, Alshawi AM, Ahmed GY, Almusabeh HM, Alghareeb TT, Alghuwainem AA, Alsulaiman ZA, Alabdulmuhsin MA, AlBuwaidi EA, Dukhi AKB, Mufti HN, Al-Qahtani M, Dhama K, Al-Tawfiq JA, Al-Omari A. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis. Allergy Asthma Clin Immunol 2021;17:109. [PMID: 34656181 DOI: 10.1186/s13223-021-00613-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
18 Onn PY, Chang CL. Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer-BioNTech mRNA COVID-19 vaccine administration. Respirol Case Rep 2021;9:e0860. [PMID: 34631106 DOI: 10.1002/rcr2.860] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Young J, Mercieca L, Ceci M, Pisani D, Betts A, Boffa MJ. A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34547137 DOI: 10.1111/jdv.17676] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
20 McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, Chamberlin G, Fathy R, Nazarian RM, Desai SR, Lim HW, Thiers BH, Hruza GJ, French LE, Blumenthal K, Fox LP, Freeman EE. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. J Am Acad Dermatol 2021:S0190-9622(21)02442-7. [PMID: 34517079 DOI: 10.1016/j.jaad.2021.09.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 22.0] [Reference Citation Analysis]
21 Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr 2021;112:828-36. [PMID: 34483343 DOI: 10.1016/j.adengl.2021.07.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Niebel D, Novak N, Wilhelmi J, Ziob J, Wilsmann-Theis D, Bieber T, Wenzel J, Braegelmann C. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Vaccines (Basel) 2021;9:944. [PMID: 34579181 DOI: 10.3390/vaccines9090944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
23 Nastro F, Fabbrocini G, di Vico F, Marasca C. Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34310759 DOI: 10.1111/jdv.17550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
24 Novak N, Tordesillas L, Cabanillas B. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int Rev Immunol 2021;:1-10. [PMID: 34251972 DOI: 10.1080/08830185.2021.1939696] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
25 Cazzato G, Romita P, Foti C, Cimmino A, Colagrande A, Arezzo F, Sablone S, Barile A, Lettini T, Resta L, Ingravallo G. Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives. Vaccines (Basel) 2021;9:760. [PMID: 34358176 DOI: 10.3390/vaccines9070760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
26 Ayatollahi A, Hosseini H, Firooz R, Firooz A. COVID-19 vaccines: What dermatologists should know? Dermatol Ther 2021;:e15056. [PMID: 34232548 DOI: 10.1111/dth.15056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
27 Tessas I, Kluger N. Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34058038 DOI: 10.1111/jdv.17422] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
28 Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 Vaccines and the Skin: The Landscape of Cutaneous Vaccine Reactions Worldwide. Dermatol Clin 2021;39:653-73. [PMID: 34556254 DOI: 10.1016/j.det.2021.05.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 23] [Article Influence: 22.5] [Reference Citation Analysis]
29 Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr 2021:S0001-7310(21)00203-9. [PMID: 34052201 DOI: 10.1016/j.ad.2021.05.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 N Sheehan K, Zhao D. Pulmonary embolism after COVID-19 vaccination. J Case Rep Images Med 2021;7:1. [DOI: 10.5348/100064z09ks2021cs] [Reference Citation Analysis]